15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $94.2B | $26.8B | 67.9% | 0.0% | $19.7B | $49.9B | $19.7B |
| 2024 | $88.8B | $14.1B | 69.1% | 0.0% | $19.8B | $38.4B | $24.1B |
| 2023 | $85.2B | $35.2B | 68.8% | 0.0% | $18.2B | $30.8B | $21.9B |
| 2023 | $80.0B | $17.9B | 69.3% | 0.0% | $17.2B | $41.2B | $12.9B |
| 2022 | $78.7B | $20.9B | 70.3% | 0.0% | $19.8B | $35.9B | $14.5B |
| 2021 | $82.6B | $14.7B | 65.6% | 0.0% | $20.2B | $37.1B | $14.0B |
| 2019 | $82.1B | $15.1B | 66.4% | 0.0% | $19.9B | $27.7B | $17.3B |
| 2018 | $81.6B | $15.3B | 66.8% | 0.0% | $18.5B | $33.1B | $18.1B |
| 2017 | $76.5B | $1.3B | 66.7% | 0.0% | $17.8B | $36.1B | $17.8B |
| 2017 | $71.9B | $16.5B | 69.7% | 0.0% | $15.5B | $28.8B | $19.0B |
| 2016 | — | $15.4B | — | — | $16.1B | $19.9B | $13.7B |
| 2014 | — | $16.3B | — | — | $15.0B | $18.8B | $14.5B |
| 2013 | — | $13.8B | — | — | $13.8B | $18.2B | $20.9B |
| 2012 | — | $10.9B | — | — | $12.5B | $16.2B | $14.9B |
| 2012 | — | $9.7B | — | — | $11.4B | $19.6B | $24.5B |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $24.1B | $5.2B | 66.3% | 0.0% | $1.5B | $55.0B | $21.7B |
| Dec '25 | $24.6B | $5.1B | 67.6% | 0.0% | $5.5B | $49.9B | $19.7B |
| Sep '25 | $24.0B | $5.2B | 69.6% | 0.0% | $8.0B | $45.8B | $18.2B |
| Jun '25 | $23.7B | $5.5B | 67.9% | 0.0% | $2.8B | $50.8B | $18.6B |
| Mar '25 | $21.9B | $11.0B | 66.4% | 0.0% | $3.4B | $52.3B | $38.5B |
| Dec '24 | $22.5B | $3.4B | 68.3% | 0.0% | $5.4B | $38.4B | $24.1B |
| Sep '24 | $22.5B | $2.7B | 69.0% | 0.0% | $7.0B | $35.8B | $20.0B |
| Jun '24 | $22.4B | $4.7B | 69.4% | 0.0% | $4.7B | $41.5B | $24.9B |
| Mar '24 | $21.4B | $3.3B | 69.6% | 0.0% | $2.9B | $33.6B | $25.5B |
| Dec '23 | $21.4B | $4.0B | 68.2% | 0.0% | $6.3B | $30.8B | $21.9B |
| Oct '23 | $21.4B | $26.0B | 69.1% | 0.0% | $6.5B | $29.9B | $19.7B |
| Jul '23 | $21.5B | $5.1B | 70.0% | 0.0% | $3.1B | $45.6B | $21.2B |
| Apr '23 | $20.9B | -$68M | 68.0% | 0.0% | $2.4B | $52.9B | $19.2B |
| Jan '23 | $19.9B | $3.5B | 69.5% | 0.0% | $3.8B | $41.2B | $12.9B |
| Oct '22 | $20.0B | $4.5B | 69.1% | 0.0% | $5.3B | $32.0B | $11.4B |
| Jul '22 | $20.2B | $4.8B | 68.7% | 0.0% | $4.7B | $32.6B | $11.0B |
| Apr '22 | $23.4B | $5.1B | 67.6% | 0.0% | $3.4B | $33.1B | $10.5B |
| Jan '22 | $24.8B | $4.7B | 67.9% | 0.0% | $4.3B | $35.9B | $14.5B |
| Oct '21 | $23.3B | $3.7B | 68.9% | 0.0% | $7.5B | $33.9B | $17.6B |
| Jul '21 | $23.3B | $6.3B | 67.5% | 0.0% | $4.5B | $33.5B | $14.3B |
How the market has priced JNJ against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Johnson & Johnson's revenue has grown 3.3% per year, and net income grown 16.2% per year. These are computed facts, not advice.
As of FY2025, Johnson & Johnson reported $49.9B of total debt against $19.7B of cash.
In FY2025, gross margin was 67.9%, operating margin —, and net margin 28.5%.
As of Jun '26, Johnson & Johnson traded at a price-to-earnings ratio of about 22.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.